China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10
Jan 24, 2025 23:00 HKT |  |
|
China Medical System (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type
Jan 09, 2025 08:00 HKT | |
|
World's first high-standard negative-pressure isolation ward built with MiC technology completes historical mission
Dec 30, 2024 20:04 HKT | |
|
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China
Dec 09, 2024 13:00 HKT | |
|
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia
Dec 02, 2024 21:30 HKT | |
|
China Medical System: First Ruxolitinib Cream's Prescriptions for Vitiligo Issued in the Greater Bay Area
Oct 21, 2024 10:00 HKT | |
|
China Medical System: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China
Sep 24, 2024 21:00 HKT | |
|
Taiwan Excellence Pavilion concludes Medical Fair Asia 2024 with Showcase of Cutting-Edge MedTech Innovations
Sep 13, 2024 17:50 HKT |  |
|
Taiwan Excellence Unveils Pioneering Medtech Innovation at Medical Fair Asia 2024
Sep 05, 2024 23:00 HKT | |
|
Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024
Aug 23, 2024 08:00 HKT |  |
|
China Medical System (00867) Released its 2024 Interim Results: Steady Increase in Revenue and Profit Compared with 2H 2023
Aug 16, 2024 13:00 HKT | |
|
An Asian Company Achieves Breakthrough in the Key Technology of Ac-225 Preparation
Aug 15, 2024 20:00 HKT |  |
|
China Medical System: NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in China
Aug 05, 2024 22:00 HKT | |
|
China Medical System (867.HK) Reincluded in S&P Global Sustainability Yearbook (China Edition) and Maintained MSCI ESG "AA" Rating
Jul 16, 2024 20:00 HKT | |
|
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China
Jun 25, 2024 20:00 HKT | |
|
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China
Jun 18, 2024 18:45 HKT | |
|
Vinmec's Innovations Spotlighted at Global CSR & ESG Summit 2024
May 09, 2024 05:04 HKT |  |
|
China Medical System: New Drug Application of Desidustat Tablets Accepted in China
Apr 23, 2024 22:00 HKT | |
|
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology
Apr 16, 2024 17:04 HKT |  |
|
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia
Apr 01, 2024 20:30 HKT | |
|